Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;135(9):3273-3279.
doi: 10.1002/lary.32214. Epub 2025 May 6.

Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis

Affiliations

Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis

Shengjie Ying et al. Laryngoscope. 2025 Sep.

Abstract

Objective: Idiopathic subglottic stenosis (iSGS) is a rare disease characterized by narrowing of the upper airway and affects near-exclusively females. Patients often experience recurrent disease and require repeated surgical dilations. The pathophysiology underlying the broad spectrum of disease severity within iSGS remains unknown. In the current study, we sought to identify transcriptomic differences between iSGS patients with markedly different recurrence rates.

Methods: Prospectively collected clinical and bulk RNA sequencing data from subglottic tissues of 56 female iSGS patients with 1-4 years of follow-up were analyzed. DESeq2 was used to perform differential expression analysis, comparing samples from the highest (1.19-1.87 dilations/year) versus the lowest (0.30-0.65 dilations/year) quartile of surgical dilation rate (i.e., high vs. low recurrence groups).

Results: In total, 220 genes were significantly differentially expressed between the high and low recurrence groups (adjusted p < 0.1 and log2 fold change > |1|). Pathway enrichment analyses showed that the high recurrence group had significantly increased expression of genes involved in adaptive immune responses (e.g., immunoglobulin subunit genes) and extracellular matrix organization (e.g., COMP, NID2) (adjusted p < 0.1). In contrast, the low recurrence group had significantly increased expression of genes involved in cilia structure and function (e.g., CFAP43, DNAI2) (adjusted p < 0.1), suggesting a relatively increased abundance of respiratory cilia.

Conclusion: Transcriptomic profiling suggests that lower recurrence rates in iSGS are associated with retention of respiratory cilia, while adaptive immune responses and increased extracellular matrix deposition are present in those with higher recurrence rates. These results hold promise for the development of prognostic markers and identification of therapeutic targets for iSGS.

Keywords: B cell; RNA sequencing; adaptive immunity; extracellular matrix; fibrosis; idiopathic subglottic stenosis (iSGS); surgical endoscopic dilation.

PubMed Disclaimer

Conflict of interest statement

A.C.N. has research funding from Novartis Canada, Merck Canada, LabCorp, and Droplet Biosciences for studies that are unrelated to the submitted work. He has equity from and is a consultant for NEED Inc. M.J.C. has research funding from Astra Zeneca, Merck, and Pfizer. He has received payment for speaker honorarium and/or served on advisory boards for Eli Lilly Merck, Astra Zeneca, and Amgen. M.J.C. has equity from and is a consultant for NEED Inc. A.H.K. has consulted for Merck Inc. and serves on the advisory board for Pentax Inc., both unrelated to the current study. P.Y.F.Z., J.W.B., J.S.M., and A.C.N. hold patents for transcriptional biomarkers in head and neck cancer, unrelated to this work. The other authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Volcano plot of differential gene expression analysis comparing subglottic tissue samples from patients with idiopathic subglottic stenosis (iSGS) in the high vs. low recurrence groups. Color indicates genes that had significantly higher expression in the high recurrence group (purple) or in the low recurrence group (orange). The dashed lines indicate the differential gene expression cut‐offs for log2 fold change > |1| (vertical) and adjusted p < 0.1 (horizontal). See Table S3 for the full list of genes tested for differential expression. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
FIGURE 2
FIGURE 2
Dotplots (left) and enrichment maps (right) showing gene sets that contain an overrepresentation of genes with significantly higher expression in (A) the high recurrence group and (B) the low recurrence group. The top 15 gene sets, ranked by gene ratio, are shown for each group. Enrichment map connectivity (gray lines) is based on the number of overlapping genes between gene sets (nodes). See Tables S4 and S5 for the full list of gene sets and the genes they contain. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]

References

    1. Maldonado F., Loiselle A., DePew Z. S., et al., “Idiopathic Subglottic Stenosis: An Evolving Therapeutic Algorithm,” Laryngoscope 124, no. 2 (2014): 498–503, 10.1002/lary.24287. - DOI - PubMed
    1. Gelbard A., Donovan D. T., Ongkasuwan J., et al., “Disease Homogeneity and Treatment Heterogeneity in Idiopathic Subglottic Stenosis,” Laryngoscope 126, no. 6 (2016): 1390–1396, 10.1002/lary.25708. - DOI - PMC - PubMed
    1. Lin R. J., Zeng P. Y. F., Fung K., et al., “Cohort‐Level Clinical Trajectory and Molecular Landscape of Idiopathic Subglottic Stenosis for Precision Laryngology—A Study of the Canadian Airways Research (CARE) Group,” eBioMedicine 114 (2025): 105629, 10.1016/j.ebiom.2025.105629. - DOI - PMC - PubMed
    1. Gelbard A., Anderson C., Berry L. D., et al., “Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis,” JAMA Otolaryngology—Head and Neck Surgery 146, no. 1 (2020): 20–29, 10.1001/jamaoto.2019.3022. - DOI - PMC - PubMed
    1. Fiz I., Koelmel J. C., Piazza C., et al., “Predictors of Recurrence After Surgical Treatment of Idiopathic Progressive Subglottic Stenosis,” Acta Otorhinolaryngologica Italica 38, no. 5 (2018): 417–423, 10.14639/0392-100X-1872. - DOI - PMC - PubMed

LinkOut - more resources